Date published: 2026-8-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

TGF beta Receptor 1/TGFBR1 CRISPR/Cas9 KO Plasmid (m): sc-423370

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: mouse
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • TGF beta Receptor 1/TGFBR1 CRISPR/Cas9 Knockout (KO) Plasmid (m) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
  • gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the TGF beta Receptor 1/TGFBR1 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
  • TGF beta Receptor 1/TGFBR1 HDR Plasmid (m) (sc-423370-HDR) is recommended for co-transfection with TGF beta Receptor 1/TGFBR1 CRISPR/Cas9 KO Plasmid (m) to enable selection of successfully edited cells through HDR-mediated integration of a puromycin resistance cassette and RFP reporter gene
  • TGF beta Receptor 1/TGFBR1 HDR Plasmid (m) is a pool of plasmids, each containing a homology-directed repair (HDR) template corresponding to the gRNA target sites in the TGF beta Receptor 1/TGFBR1 CRISPR/Cas9 KO Plasmid (m)
  • Each HDR plasmid contains two ~800 bp homology arms flanking the puromycin resistance and RFP cassettes, designed to bind genomic DNA sequences surrounding the Cas9-induced double-strand break site and facilitate precise HDR-mediated integration
  • The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
  • Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: TGF beta Receptor 1/TGFBR1 Antibody (RM0016-3A11): sc-101574
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    TGF beta Receptor 1/TGFBR1 CRISPR/Cas9 KO Plasmid (m)

    sc-423370
    20 µg
    $397.00

    TGF beta Receptor 1/TGFBR1 HDR Plasmid (m)

    sc-423370-HDR
    20 µg
    $445.00

    Overview

    Mouse Tgfbr1 encodes TGF beta receptor 1 (TGFBR1/ALK5), a serine/threonine kinase that partners with TGFBR2 to transduce TGF-β signals through phosphorylation of SMAD2/SMAD3 and engagement of non-canonical pathways such as MAPK, PI3K/AKT, and Rho-like GTPases. This receptor regulates cell fate decisions including proliferation control, differentiation, epithelial–mesenchymal transition, immune modulation, and extracellular matrix remodeling. Perturbation of TGFBR1 signaling is associated with altered tissue homeostasis and fibrotic remodeling, and it is frequently studied in the context of tumor microenvironment biology and developmental phenotypes in mouse models.

    TGF beta Receptor 1/TGFBR1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Tgfbr1 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Tgfbr1 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.

    When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.

    Homology-Directed Repair (HDR) Donor — Puromycin Cassette with RFP Reporter

    For applications requiring confirmed, selectable knockout clones, TGF beta Receptor 1/TGFBR1 HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Tgfbr1 target site.
    When co-transfected with TGF beta Receptor 1/TGFBR1 CRISPR/Cas9 KO Plasmid (m):

    • The PuroR-RFP cassette integrates at the Cas9 cut site via HDR, disrupting the Tgfbr1 open reading frame.
    • RFP fluorescence provides an immediate visual indicator of successful integration, enabling fluorescence-based identification or sorting of edited cells prior to or alongside puromycin selection.
    • Successfully edited cells are confirmed through puromycin resistance, substantially reducing clone screening burden.
    • This selection strategy is ideal for generating stable, clonal KO cell lines for downstream functional studies, drug screening, or model development.

    Cre-lox Cassette Removal System

    The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Tgfbr1 locus and eliminating potential confounding effects on downstream assays.
    This two-step approach:

    • Minimizes disruption to local chromatin architecture and neighboring regulatory elements
    • Restores a near-native genomic context at the edited locus
    • Enables reuse of the puromycin selection strategy in the same cell line for additional edits

    Key Features

    • gRNA targeting Tgfbr1 exon(s) critical for TGF beta Receptor 1/TGFBR1 function
    • Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
    • HDR donor with puromycin resistance for positive clone selection
    • loxP-flanked PuroR cassette with Cre recombinase vector for seamless marker removal
    • Supplied ready to use for delivery by transfection

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.